Aarti Drugs

AARTIDRUGS.NSPre-clinical

Aarti Drugs Limited is a prominent, vertically integrated Indian pharmaceutical company specializing in the development and manufacturing of a wide range of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. With a robust manufacturing infrastructure and a significant export footprint, the company serves as a critical supplier to the global generic pharmaceutical industry. Its strategic focus on cost-competitive manufacturing, regulatory compliance, and portfolio expansion in niche therapeutic segments underpins its market position and growth trajectory.

Market Cap

$335.1M

Employees

1000-2000

Focus

Biotech

AARTIDRUGS.NS · Stock Price

USD 343.8098.00 (-22.18%)

Historical price data

AI Company Overview

Technology Platform

Advanced chemical synthesis and process engineering for the scalable, cost-effective manufacturing of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates.

Funding History

IPOUndisclosedUndisclosedJun 15, 2008

Opportunities

Growth is driven by the 'China Plus One' supply chain diversification trend, increasing global demand for generic drugs, and expansion into niche, high-value APIs.

The large and growing domestic Indian pharmaceutical market provides a stable foundation.

Risk Factors

Key risks include regulatory actions against manufacturing facilities, intense price competition in the API market, volatility in raw material costs (especially from China), and currency exchange rate fluctuations impacting export profitability.

Competitive Landscape

Competes with large Indian API manufacturers like Divi's Labs and Dr. Reddy's, as well as Chinese producers. Differentiation is based on a broad therapeutic portfolio, regulatory compliance, vertical integration, and a reputation as a reliable quality supplier.

Publications